Explainable Artificial Intelligence for Drug Discovery and Development

Share this:
Published: 7 Sep 2018

This Genetic Technology TOE encompasses recent advances in artificial intelligence platforms enabling drug discovery and development, while highlighting the importance of explainability in AI-driven technologies for healthcare. The TOE also provides an overview of the AI value chain. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Explainable artificial intelligence, drug discovery, machine learning, Natural Language Processing, NLP



Features of this research


Help Desk

Full list of offices

For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..